Cellectis (CLLS) Tops Q4 EPS by 19c

Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.54), $0.19 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $3.08 million versus the consensus estimate of $4.95 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Sherwin-Williams climbs 18% off 52-week low as Citi sets $380 target
• Piper Sandler picks Payments and Consumer Finance winners as multiples reset